<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gastrointestinal Drugs - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>üçΩÔ∏è</span>
                        <span>Section X</span>
                    </div>
                    <h1 class="document-title">Drugs Used in Disorders of the Gastrointestinal Tract</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Obesity, Lipids, Vomiting, Diarrhoea, Constipation & Peptic Ulcer</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>90 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 40 -->
                    <section class="content-section" id="chapter-40">
                        <div class="section-header">
                            <div class="section-number">40</div>
                            <h2 class="section-title">
                                <span class="title-icon">üçî</span>
                                Appetite, Obesity and Hypolipidemic Agents
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Appetite Stimulants</h3>
                            <p>Used for anorexia in debilitating illnesses. <strong>Alcohol</strong> (small quantities) stimulates gastric secretion but chronic use causes gastritis. <strong>Cyproheptadine</strong> (5-HT antagonist) has appetite stimulating properties but causes drowsiness. <strong>Megestrol acetate</strong> is used in cancer cachexia.</p>

                            <h3>Treatment of Obesity (Anorexiants)</h3>
                            <p>Obesity is a disorder of energy balance. Drug therapy is adjunctive to diet and exercise.</p>
                            
                            <h4>1. Centrally Acting Anorexiants</h4>
                            <ul>
                                <li><strong>Adrenergic agents:</strong> Amphetamine (high abuse potential), Phentermine, Diethylpropion.</li>
                                <li><strong>5-HT Agonists:</strong> Fenfluramine (Withdrawn due to valvular heart disease), <strong>Lorcaserin</strong> (selective $5-HT_{2C}$ agonist).</li>
                                <li><strong>Sibutramine:</strong> Withdrawn due to cardiovascular toxicity.</li>
                            </ul>

                            <h4>2. Peripherally Acting Agents</h4>
                            <p><strong>Orlistat:</strong> Inhibits gastric and pancreatic lipases. Prevents absorption of about 30% of dietary fat.
                            <br><strong>Adverse Effects:</strong> Oily spotting, flatus with discharge, fecal urgency, steatorrhoea. May reduce absorption of fat-soluble vitamins.</p>

                            <h3>Antihyperlipidemic Drugs</h3>
                            <p>Used to treat elevated cholesterol (risk factor for atherosclerosis/IHD) and triglycerides (risk of pancreatitis).</p>

                            <h4>1. Statins (HMG-CoA Reductase Inhibitors)</h4>
                            <p><strong>Mechanism:</strong> Inhibit the rate-limiting enzyme in cholesterol synthesis. Leads to upregulation of LDL receptors on hepatocytes and increased clearance of LDL from blood.</p>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <thead>
                                        <tr>
                                            <th>Drug</th>
                                            <th>Intensity</th>
                                            <th>Key Features</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Atorvastatin</strong></td>
                                            <td>High</td>
                                            <td>Long $t^{1/2}$. Taken any time of day. Potent.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Rosuvastatin</strong></td>
                                            <td>High</td>
                                            <td>Potent. Long $t^{1/2}$.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Simvastatin</strong></td>
                                            <td>Moderate</td>
                                            <td>Prodrug. Take at night. CYP3A4 interactions.</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Pravastatin</strong></td>
                                            <td>Moderate</td>
                                            <td>Hydrophilic. Less drug interactions.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p><strong>Adverse Effects:</strong> Myalgia, Myopathy, Rhabdomyolysis (rare but serious, risk increased with fibrates/CYP inhibitors), hepatotoxicity.</p>

                            <h4>2. Fibrates (Fibric Acid Derivatives)</h4>
                            <p><strong>Gemfibrozil, Fenofibrate.</strong> Activators of PPAR-$\alpha$. markedly reduce Triglycerides (by 50%) and increase HDL. Used in hypertriglyceridemia.</p>

                            <h4>3. Cholesterol Absorption Inhibitors</h4>
                            <p><strong>Ezetimibe:</strong> Inhibits intestinal absorption of cholesterol. Synergistic with statins.</p>

                            <h4>4. Bile Acid Sequestrants (Resins)</h4>
                            <p><strong>Cholestyramine:</strong> Binds bile acids in gut, preventing enterohepatic circulation. Unpleasant taste, GI bloating.</p>

                            <h4>5. Nicotinic Acid (Niacin)</h4>
                            <p>Reduces VLDL and LDL, increases HDL significantly.
                            <br><strong>Side Effects:</strong> Intense cutaneous flushing (mediated by PGs, reduced by aspirin), pruritus, hepatotoxicity.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 40 -->

                    <!-- START: Chapter 41 -->
                    <section class="content-section" id="chapter-41">
                        <div class="section-header">
                            <div class="section-number">41</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü§Æ</span>
                                Antiemetics and Drug Therapy of Diarrhoea
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Pharmacotherapy of Vomiting</h3>
                            <p>Vomiting centre is stimulated by CTZ (Chemoreceptor Trigger Zone), vestibular apparatus, and peripheral afferents.</p>

                            <h4>Classification of Antiemetics</h4>
                            <div class="grid grid-2">
                                <div class="grid-item">
                                    <h4>1. 5-HT3 Antagonists</h4>
                                    <p><strong>Ondansetron, Granisetron.</strong> Potent. Block receptors in CTZ and GI tract. Drug of choice for chemotherapy/radiation induced vomiting and post-op vomiting.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>2. D2 Blockers (Prokinetics)</h4>
                                    <p><strong>Metoclopramide:</strong> Central antiemetic + Prokinetic (increases gastric emptying). Side effects: Extrapyramidal reactions (dystonia).
                                    <br><strong>Domperidone:</strong> Does not cross BBB. Less side effects.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>3. Antihistaminics/Anticholinergics</h4>
                                    <p><strong>Promethazine, Dimenhydrinate, Scopolamine (Hyoscine).</strong> Useful for <strong>Motion Sickness</strong> and vestibular disorders.</p>
                                </div>
                                <div class="grid-item">
                                    <h4>4. NK1 Antagonists</h4>
                                    <p><strong>Aprepitant.</strong> Blocks Substance P actions. Used for delayed chemotherapy induced vomiting.</p>
                                </div>
                            </div>

                            <h3>Pharmacotherapy of Diarrhoea</h3>
                            <p>Priorities: 1. Rehydration (ORT/IV), 2. Maintenance of Nutrition, 3. Specific Antimicrobials (if infective), 4. Symptomatic relief.</p>

                            <h4>1. Oral Rehydration Therapy (ORT)</h4>
                            <p>Based on coupled transport of Sodium and Glucose in the intestine.</p>
                            <div class="table-responsive">
                                <table class="content-table">
                                    <caption>Table 41.7: WHO ORS Composition (Reduced Osmolarity)</caption>
                                    <thead>
                                        <tr>
                                            <th>Component</th>
                                            <th>Amount (g/L)</th>
                                            <th>Concentration (mmol/L)</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td>Sodium Chloride</td>
                                            <td>2.6</td>
                                            <td>Sodium: 75</td>
                                        </tr>
                                        <tr>
                                            <td>Glucose (Anhydrous)</td>
                                            <td>13.5</td>
                                            <td>Glucose: 75</td>
                                        </tr>
                                        <tr>
                                            <td>Potassium Chloride</td>
                                            <td>1.5</td>
                                            <td>Potassium: 20</td>
                                        </tr>
                                        <tr>
                                            <td>Trisodium Citrate</td>
                                            <td>2.9</td>
                                            <td>Citrate: 10, Chloride: 65</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Total Osmolarity</strong></td>
                                            <td></td>
                                            <td><strong>245 mOsm/L</strong></td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p><strong>Zinc Supplementation:</strong> 20 mg/day (10 mg for infants) for 14 days reduces duration and severity.</p>

                            <h4>2. Antimotility Drugs</h4>
                            <p><strong>Loperamide:</strong> Opioid agonist. Decreases motility and secretions. <strong>Contraindicated</strong> in acute infective diarrhoea (dysentery) and in children < 2 years (risk of ileus/respiratory depression).</p>
                            <p><strong>Racecadotril:</strong> Enkephalinase inhibitor. Antisecretory. Safe in children.</p>

                            <h4>3. Antimicrobials</h4>
                            <p>Indicated for: Shigellosis, Cholera, Giardiasis, Amoebic dysentery. (See Section XII).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 41 -->

                    <!-- START: Chapter 42 -->
                    <section class="content-section" id="chapter-42">
                        <div class="section-header">
                            <div class="section-number">42</div>
                            <h2 class="section-title">
                                <span class="title-icon">üöΩ</span>
                                Pharmacotherapy of Constipation
                            </h2>
                        </div>

                        <div class="content-card">
                            <p><strong>Laxatives</strong> (mild) or <strong>Cathartics</strong> (strong) promote defecation. Non-drug measures (fibre, water, exercise) are first line.</p>

                            <h3>Classification</h3>
                            <ul>
                                <li><strong>Bulk Laxatives:</strong> Ispaghula (Psyllium), Methylcellulose, Bran. Absorb water, swell, stretch bowel to stimulate peristalsis. Safe.</li>
                                <li><strong>Osmotic Laxatives:</strong>
                                    <ul>
                                        <li><strong>Lactulose:</strong> Non-absorbable disaccharide. Metabolised by colon bacteria to acids $\to$ osmotic retention of water. Also traps $NH_3$ (used in Hepatic Encephalopathy).</li>
                                        <li><strong>Magnesium Salts (Milk of Magnesia):</strong> Saline purgatives. Rapid action.</li>
                                        <li><strong>PEG (Polyethylene Glycol):</strong> For bowel preparation.</li>
                                    </ul>
                                </li>
                                <li><strong>Stimulant (Irritant) Laxatives:</strong>
                                    <ul>
                                        <li><strong>Bisacodyl, Sodium Picosulfate:</strong> Act on colon.</li>
                                        <li><strong>Senna:</strong> Anthraquinone derivative. May cause melanosis coli.</li>
                                        <li><strong>Castor Oil:</strong> Small intestine irritant. Drastic purgative. Avoid in pregnancy.</li>
                                    </ul>
                                </li>
                                <li><strong>Stool Softeners (Emollients):</strong> Liquid Paraffin (interferes with vitamin absorption), Docusate Sodium.</li>
                                <li><strong>Chloride Channel Activators:</strong> Lubiprostone (for IBS-constipation).</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: Chapter 42 -->

                    <!-- START: Chapter 43 -->
                    <section class="content-section" id="chapter-43">
                        <div class="section-header">
                            <div class="section-number">43</div>
                            <h2 class="section-title">
                                <span class="title-icon">üî•</span>
                                Pharmacotherapy of Peptic Ulcer Disease
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>Peptic ulcer (Duodenal/Gastric) results from imbalance between aggressive factors (Acid, Pepsin, H. pylori, NSAIDs) and defensive factors (Mucus, Bicarbonate, Prostaglandins).</p>

                            <h3>I. Drugs Inhibiting Acid Secretion</h3>
                            
                            <h4>1. Proton Pump Inhibitors (PPIs)</h4>
                            <p><strong>Omeprazole, Pantoprazole, Lansoprazole, Rabeprazole, Esomeprazole.</strong>
                            <br><strong>Mechanism:</strong> Irreversibly inhibit $H^+-K^+$ ATPase (Proton Pump) in parietal cells. Most potent acid suppressors.
                            <br><strong>Administration:</strong> Prodrugs. Activated in acidic canaliculi. Best taken empty stomach (30 min before meal).
                            <br><strong>Uses:</strong> Peptic Ulcer, GERD (Drug of choice), Zollinger-Ellison Syndrome, H. pylori eradication, NSAID ulcer prevention.
                            <br><strong>Adverse Effects:</strong> GI upset, headache. Long term: B12 deficiency, osteoporosis risk.</p>

                            <h4>2. H2 Receptor Antagonists</h4>
                            <p><strong>Ranitidine, Famotidine, Cimetidine.</strong>
                            <br><strong>Mechanism:</strong> Competitively block $H_2$ receptors on parietal cells. Suppress basal and nocturnal acid secretion.
                            <br><strong>Cimetidine:</strong> Inhibits CYP450 (drug interactions), Anti-androgenic (gynecomastia). Ranitidine/Famotidine are preferred (fewer side effects).</p>

                            <h3>II. Mucosal Protective Agents</h3>
                            <ul>
                                <li><strong>Sucralfate:</strong> Polymerises in acid pH to form a sticky gel that adheres to ulcer base. Physical barrier. Causes constipation.</li>
                                <li><strong>Misoprostol:</strong> $PGE_1$ analogue. Cytoprotective and inhibits acid. Specific for <strong>NSAID-induced ulcers</strong>. Side effects: Diarrhoea, uterine cramps (abortifacient - avoid in pregnancy).</li>
                                <li><strong>Bismuth compounds:</strong> Coat ulcer, anti-H. pylori action.</li>
                            </ul>

                            <h3>III. Antacids</h3>
                            <p>Neutralize secreted acid. For symptomatic relief.
                            <br><strong>Systemic:</strong> Sodium bicarbonate (can cause alkalosis).
                            <br><strong>Non-systemic:</strong> Magnesium hydroxide (Laxative) + Aluminium hydroxide (Constipating). Often combined to balance bowel effect.</p>

                            <h3>IV. Anti-H. pylori Therapy</h3>
                            <p>Eradication prevents recurrence. Triple therapy is standard.</p>
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 43.6: H. pylori Eradication Regimens (10-14 days)</caption>
                                    <thead>
                                        <tr>
                                            <th>Regimen</th>
                                            <th>Drugs</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Standard Triple Therapy</strong></td>
                                            <td><strong>PPI</strong> (standard dose bid) +<br><strong>Clarithromycin</strong> (500 mg bid) +<br><strong>Amoxicillin</strong> (1000 mg bid) OR <strong>Metronidazole</strong> (400 mg bid)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Quadruple Therapy</strong> (for resistant cases)</td>
                                            <td>PPI + Bismuth + Tetracycline + Metronidazole</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 43 -->
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-09.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section IX: Renal Drugs</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>10</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 62.5%;"></div>
                            </div>
                            <div class="progress-label">Section 10 of 16</div>
                        </div>
                        
                        <a href="section-11.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section XI: Oxytocics</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>